bellerophon
present
two
september
investor
conferences
warren
globe
newswire
bellerophon
therapeutics
nasdaq
blph
bellerophon
company
biotherapeutics
company
focused
developing
treatments
cardiopulmonary
infectious
diseases
announced
today
fabian
tenenbaum
chief
executive
officer
present
two
investor
conferences
september
wainwright
annual
global
investment
conference
cantor
fitzgerald
virtual
global
healthcare
conference
wainwright
annual
global
investment
conference
date
monday
september
time
pm
et
cantor
fitzgerald
virtual
global
healthcare
conference
date
thursday
september
time
pm
et
live
audio
webcast
replay
presentations
available
investors
section
company
website
bellerophon
bellerophon
therapeutics
biotherapeutics
company
focused
developing
innovative
therapies
address
significant
unmet
medical
needs
treatment
cardiopulmonary
infectious
diseases
company
currently
developing
multiple
product
candidates
program
proprietary
pulsatile
nitric
oxide
delivery
system
information
please
visit
contacts
group
lifesci
advisors
julie
normart
brian
ritchie
jnormart
britchie
